Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Johnson & Johnson
Current Parent Company: Johnson & Johnson
Penalty: $25,000,000
Year: 2023
Date: March 15, 2023
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Secondary Offense: generic drug pay for delay
Mega-Scandal: Generic Drug Pay for Delay
Violation Description: Johnson & Johnson agreed to pay $25 million to settle litigation alleging that it took improper steps to prevent customers from purchasing lower-cost biosimilar alternatives to its Remicade treatment for inflammatory diseases.
Level of Government: federal
Action Type: private litigation
Court: Eastern District of Pennsylvania
Civil or Criminal Case: civil
Case ID: 2:17cv4326
Case Name: National Employees Health Plan v. Johnson & Johnson et al
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: USA
HQ State of Current Parent: New Jersey
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.